Health & Biotech
Optiscan Imaging Ltd (ASX:OIL) is a global leader in the development, manufacturing, and commercialisation of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Our technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level.
We are driven by developing technology and its use to give healthcare providers and researchers the highest quality real-time microscopic imaging tools to enable the early detection and management of disease, improve patient outcomes, and reduce the high cost of curative medicine and associated procedures.
Our patent-protected proprietary technology, using specially miniaturised componentry, has created a pen-sized digital microscope, which can be used on any tissue it contacts to produce high resolution digital pathology images for cancer diagnosis and surgical margin detection in real-time. The aim of our technology development is for earlier diagnosis and subsequent treatment of cancerous tumours with expected associated improved patient outcomes.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Stockhead TV
Long Shortz with Optiscan Imaging: the future of pathology is here
Health & Biotech
Optiscan unveils ‘digital pathology workhorse’ to speed up diagnostics
Health & Biotech
Health Check: EBOS Group’s earnings surge – or plunge – but bottom line is, pharmacies are in rude health
Health & Biotech
Optiscan kicks off GI study in Germany with first imaging prototype
Health & Biotech
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidance
Health & Biotech
The ASX biotechs aiming to catch cancer early
Health & Biotech
Optiscan inks deal with US uni to diagnose cancer in animals
News
Closing Bell: ASX slips as MinRes rebounds, RBA holds; and are traders exiting ‘Trump trades’?
Health & Biotech
Optiscan inks deal with Monash Uni to progress GI scope
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Health & Biotech
ASX health stocks developing tech to bridge labour gaps
Long Shortz
Long Shortz with Optiscan: OIL targets massive US veterinary market at major healthcare events
Health & Biotech
Biocurious: Optiscan aims for cancer surgery to be done right all the time, first time
Health & Biotech
ASX medical disruptors pioneering new diagnostics and cutting-edge procedures
Health & Biotech
ASX stocks leading clinical trials in Australia
News
Closing Bell: Gold, utilities soar as A2 Milk sags; ASX 200 keeps winning streak alive
Health & Biotech